Redsense Medical AB (publ) (XSAT:REDS)
Sweden · Delayed Price · Currency is SEK 4.440
+0.340 (8.29%)
At close: Jun 11, 2026
Redsense Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 28.7 | 26.8 | 28.77 | 25.52 | 16.75 | 16.34 |
Other Revenue | - | - | - | - | 0 | - |
| 28.7 | 26.8 | 28.77 | 25.52 | 16.75 | 16.34 | |
Revenue Growth (YoY) | -10.08% | -6.84% | 12.74% | 52.32% | 2.51% | -4.43% |
Cost of Revenue | 10.21 | 11.24 | 10.69 | 12.36 | 5.49 | 5.95 |
Gross Profit | 18.5 | 15.56 | 18.08 | 13.16 | 11.27 | 10.4 |
Selling, General & Admin | 19.4 | 18.66 | 19.76 | 17.54 | 22.46 | 22.77 |
Other Operating Expenses | - | - | - | 0.59 | -1.04 | -0.56 |
Operating Expenses | 20.36 | 19.28 | 19.83 | 18.2 | 21.47 | 22.39 |
Operating Income | -1.87 | -3.72 | -1.75 | -5.04 | -10.21 | -11.99 |
Interest Expense | -0.03 | -0.03 | -0.04 | -0.03 | -0.1 | -0.05 |
Interest & Investment Income | 0.27 | 0.23 | 0.17 | 0.06 | 1.02 | 1.05 |
Earnings From Equity Investments | - | - | - | - | - | -0.3 |
Currency Exchange Gain (Loss) | -1.27 | -3.65 | 1.96 | - | 2.5 | - |
Other Non Operating Income (Expenses) | -0 | - | - | - | -0 | 0 |
EBT Excluding Unusual Items | -2.9 | -7.17 | 0.34 | -5.01 | -6.79 | -11.29 |
Gain (Loss) on Sale of Investments | - | - | - | 0.5 | -1.97 | 3.32 |
Pretax Income | -2.9 | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 |
Net Income | -2.9 | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 |
Net Income to Common | -2.9 | -7.17 | 0.34 | -4.51 | -8.76 | -7.97 |
Shares Outstanding (Basic) | 18 | 18 | 17 | 14 | 14 | 14 |
Shares Outstanding (Diluted) | 18 | 18 | 17 | 14 | 14 | 14 |
Shares Change (YoY) | 0.03% | 4.85% | 21.25% | -0.16% | 0.60% | - |
EPS (Basic) | -0.16 | -0.40 | 0.02 | -0.32 | -0.62 | -0.57 |
EPS (Diluted) | -0.16 | -0.40 | 0.02 | -0.32 | -0.62 | -0.57 |
Free Cash Flow | -3.23 | -5.23 | -8.25 | -5.1 | -9.83 | -12.58 |
Free Cash Flow Per Share | -0.18 | -0.29 | -0.48 | -0.36 | -0.70 | -0.90 |
Gross Margin | 64.44% | 58.06% | 62.83% | 51.56% | 67.24% | 63.63% |
Operating Margin | -6.50% | -13.87% | -6.10% | -19.74% | -60.93% | -73.37% |
Profit Margin | -10.11% | -26.76% | 1.19% | -17.69% | -52.27% | -48.78% |
Free Cash Flow Margin | -11.25% | -19.51% | -28.66% | -20.00% | -58.68% | -76.98% |
EBITDA | -1.46 | -3.65 | -1.69 | -4.98 | -10.16 | -11.97 |
EBITDA Margin | -5.07% | -13.60% | -5.87% | -19.50% | -60.61% | -73.21% |
D&A For EBITDA | 0.41 | 0.07 | 0.07 | 0.06 | 0.05 | 0.03 |
EBIT | -1.87 | -3.72 | -1.75 | -5.04 | -10.21 | -11.99 |
EBIT Margin | -6.50% | -13.87% | -6.10% | -19.74% | -60.93% | -73.37% |
Revenue as Reported | 29.12 | 26.8 | 32.63 | 25.56 | 17.79 | 16.9 |